Key Milestones
MEDICAMEN Biotech has constantly strived to be on the path of growth on the strength of its brilliant human resource, world class facilities and a global vision of its Management.
From being a purely Formulation manufacturer of general products, the Company has diversified into setting up a state-of-the-art R&D Centre followed by a most modern API manufacturing facility and, lastly, setting up a highly auditable facility for manufacturing Oncology injectables and OSDs which will stand the test of leading global regulatory agencies. Please find below our journey from humble beginnings to being a vertically integrated Group:
Chronology of Events
-
Achievements
- 1993
Medicamen established.
- 1995
IPO issued – BSE listed.
- 1996
Operations started - Bhiwadi FDF Plant
- 1998
WHO-GMP Received – Bhiwadi FDF Plant
- 2000
ISO certification – Bhiwadi FDF Plant
-
Achievements
- 2001: Global Accreditation
NDA(Uganda), ANVISA(Brazil),FM HACA( Ethiopia)-Bhiwadi FDF Plant
- 2007
Operations started – Haridwar Unit-I (FDF)
-
Achievements
- 2018
New R&D center setup along with Upgradation & Mordernization of Bhiwadi FDF plant
- 2016
Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd
- 2019: Global Accreditation
FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant
- 2020
Global API Facility started– Dahej API Plant
-
Achievements
- 2021
Operations started: Haridwar formulation Unit –II(FDF) (oncology)
- 2021
Filing API USDMFs & CEPs